Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis

The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzgerald, John P., Ercole, Barbara, Parekh, Dipen J.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Symposium
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878447/
https://www.ncbi.nlm.nih.gov/pubmed/20535294
http://dx.doi.org/10.4103/0970-1591.60448
_version_ 1782181871865561088
author Fitzgerald, John P.
Ercole, Barbara
Parekh, Dipen J.
author_facet Fitzgerald, John P.
Ercole, Barbara
Parekh, Dipen J.
author_sort Fitzgerald, John P.
collection PubMed
description The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.
format Text
id pubmed-2878447
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28784472010-06-09 Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis Fitzgerald, John P. Ercole, Barbara Parekh, Dipen J. Indian J Urol Symposium The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum. Medknow Publications 2010 /pmc/articles/PMC2878447/ /pubmed/20535294 http://dx.doi.org/10.4103/0970-1591.60448 Text en ©Indian Journal of Urology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium
Fitzgerald, John P.
Ercole, Barbara
Parekh, Dipen J.
Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
title Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
title_full Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
title_fullStr Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
title_full_unstemmed Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
title_short Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
title_sort management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878447/
https://www.ncbi.nlm.nih.gov/pubmed/20535294
http://dx.doi.org/10.4103/0970-1591.60448
work_keys_str_mv AT fitzgeraldjohnp managementofpostchemotherapyresidualmassinpatientswithmetastaticnonseminomatousgermcelltumorsofthetestis
AT ercolebarbara managementofpostchemotherapyresidualmassinpatientswithmetastaticnonseminomatousgermcelltumorsofthetestis
AT parekhdipenj managementofpostchemotherapyresidualmassinpatientswithmetastaticnonseminomatousgermcelltumorsofthetestis

Ejemplares similares